[Peritoneal recurrence prediction for colon cancer based on immunoexpression]

Area of Science:

• Oncology
• Molecular Biology
• Surgical Pathology

Background:

• Peritoneal relapse is a significant recurrence pattern in colon cancer post-colectomy.
• Current diagnostic methods have limitations in predicting peritoneal recurrence.
• There is a need for predictive tools to identify high-risk patients for targeted interventions.

Purpose of the Study:

• To evaluate epithelial-mesenchymal transition biomarkers (c-Met, IGF-1R, plexin β1) for predicting post-surgical peritoneal colonization in colon cancer.
• To develop a mathematical model for predicting carcinomatous relapse based on these biomarkers.

Main Methods:

• Retrospective analysis of 87 colon cancer patients who underwent radical resection.
• Immunohistochemical assessment of c-Met, IGF-1R, and plexin β1 expression in tumor samples.
• Statistical evaluation of biomarker association with peritoneal relapse and development of a predictive mathematical model.

Main Results:

• IGF-1 (p: .022) and plexin β1 (p: .021) showed a significant association with peritoneal relapse.
• Multivariate analysis identified c-Met and plexin β1 as key factors for a predictive model.
• The model demonstrated 75.8% sensitivity and 80.5% specificity for predicting peritoneal recurrence.

Conclusions:

• Overexpression of c-Met and plexin β1 is linked to an increased risk of peritoneal relapse in resectable colon cancer.
• The developed mathematical model shows clinical utility in identifying patients at high risk for peritoneal recurrence.
• This predictive model may aid in selecting candidates for carcinoprophylaxis.